BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,441,000 | -38.9% | 29,388 | -41.1% | 0.00% | -33.3% |
| Q2 2022 | $7,269,000 | +39.2% | 49,889 | +13.3% | 0.00% | +50.0% |
| Q1 2022 | $5,222,000 | -14.4% | 44,045 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $6,102,000 | -10.4% | 44,271 | -9.7% | 0.00% | 0.0% |
| Q3 2021 | $6,809,000 | +31.7% | 49,009 | -8.0% | 0.00% | 0.0% |
| Q2 2021 | $5,171,000 | +47.8% | 53,266 | +4.1% | 0.00% | +100.0% |
| Q1 2021 | $3,498,000 | -29.3% | 51,171 | -11.4% | 0.00% | -50.0% |
| Q4 2020 | $4,950,000 | +7.1% | 57,743 | -18.8% | 0.00% | 0.0% |
| Q3 2020 | $4,623,000 | -25.4% | 71,119 | -16.1% | 0.00% | -33.3% |
| Q2 2020 | $6,198,000 | +101.8% | 84,775 | -6.1% | 0.00% | +50.0% |
| Q1 2020 | $3,071,000 | -18.8% | 90,259 | +30.0% | 0.00% | 0.0% |
| Q4 2019 | $3,781,000 | +40.7% | 69,442 | +7.8% | 0.00% | +100.0% |
| Q3 2019 | $2,687,000 | -9.5% | 64,412 | -5.1% | 0.00% | 0.0% |
| Q2 2019 | $2,970,000 | -26.2% | 67,843 | -13.2% | 0.00% | -50.0% |
| Q1 2019 | $4,023,000 | +121.5% | 78,171 | +59.2% | 0.00% | +100.0% |
| Q4 2018 | $1,816,000 | +36.0% | 49,099 | +38.1% | 0.00% | – |
| Q3 2018 | $1,335,000 | – | 35,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |